Heparinoid Market Dynamics Focus on Raw Material Shortages and Safety Concerns Impacting Supply Chain

Global Heparinoid Market Size is valued at USD 1.2 Billion in 2024 and is predicted to reach USD 1.7 Billion by the year 2034 at a 3.6% CAGR during the forecast period for 2025-2034.

Latest Drivers Restraint and Opportunities Market Snapshot:

Key factors influencing the global Heparinoid market are:

• Rising Prevalence of Chronic Diseases Fueling the Heparin Market
• Growing Popularity of Heparin Alternatives
• The Surge in Surgical Procedures Fuels Growth in the Heparin Market

The following are the primary obstacles to the Heparinoid market’s expansion:

• Shortage of Raw Materials and Safety Concerns
• Lack of Raw Materials and Increased Prices
• High risk of side effects

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2293

Future expansion opportunities for the global Heparinoid market include:

• Robust Adoption of the Product in Various Applications
• Increasing R&D Initiatives for Synthetic Heparin to Escalate Trade Openings
• Product Advancements Driving Growth in the Heparin Market

Key Industry Insights & Findings from the report:

• Heparinoids are increasingly being used in a variety of medical therapies, including pre-surgical anticoagulant therapy and DVT prophylaxis. Heparinoid-based formulations are also becoming popular since they have a reduced risk of bleeding problems than other anticoagulants.
• High prevalence and great clinical demand for efficient anticoagulant treatment, Atrial fibrillation, a common cardiac arrhythmia, dramatically raises the risk of stroke, necessitating the use of anticoagulants such heparin to avoid thromboembolic events.
• North America led the market due to greater patient awareness, a high disease burden, active government initiatives, technology advances, and improvements in healthcare infrastructure.
• Long-term usage of Heparinoids may result in adverse consequences. Although they are typically regarded as safe, they might produce problems like as hemorrhage, thrombocytopenia, and allergic responses. These side effects may dissuade patients and healthcare professionals from choosing Heparinoid-based therapy.

Market Analysis:

The Heparinoid market is experiencing notable growth, driven by its extensive applications within the healthcare sector, particularly in the treatment and prevention of thrombosis, pulmonary embolism, and other coagulation-related disorders. Heparinoids, which are synthetic or semi-synthetic derivatives of heparin—a naturally occurring anticoagulant—are widely incorporated into pharmaceutical formulations for therapeutic use.

The rising prevalence of cardiovascular diseases, coupled with an expanding global geriatric population, is significantly contributing to the increased adoption of heparin-based therapies. These trends collectively underscore the growing clinical importance of heparinoids in modern anticoagulant treatment strategies.

List of Prominent Players in the Heparinoid Market:

• Merck KGaA
• SEIKAGAKU CORPORATION
• TSI Group Ltd.
• Synutra Pure, Ltd.
• Bioiberica S.A.U.
• Kala Health Inc.
• Beloorbayir Biotech Ltd
• Sichuan Biosyn Pharmaceutical Co., Ltd
• Seikagaku Corporation
• Jiaxing Hengjie Bio-pharmaceutical LLC
• Wright Health
• Bioiberica
• Manus Aktteva Biopharma
• Pfizer
• Hepac

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Recent Developments:

• In December 2024, Dongying Tiandong Pharmaceutical revealed that they had filed a patent application for a technique for evaluating the dope content of bovine lung heparin in pig gut mucosa heparin.
• In November 2024, Bristol Myers Squibb announces that results from their cardiovascular pipeline will be presented at the American Heart Association Annual Scientific Sessions.
• In February 2024, B. Braun Inc., a renowned business in smart infusion treatment, introduced 2000 units of heparin in 0.9% sodium chloride injections.
• In February 2024, Roche released three coagulation tests for oral Factor Xa inhibitors (apixaban, edoxaban, and rivaroxaban) in European nations with the CE mark.

Heparinoid Market Dynamics

Market Drivers: Increasing Prevalence of Chronic Diseases Boosting Heparin Demand

The growth of the heparinoid market is strongly supported by the rising incidence of chronic diseases, which often necessitate long-term medical management and intervention. Lifestyle-related factors, including sedentary behavior, poor dietary habits, and inadequate weight management, have contributed to a surge in chronic conditions such as diabetes, cardiovascular disorders, and certain cancers.

Heparin, a widely used anticoagulant during surgical procedures and medical treatments, has experienced increased demand as a result. According to the World Health Organization (WHO, April 2023), approximately 537 million individuals aged 20 to 79 were living with diabetes globally, a number projected to rise to 643 million by 2030 and 783 million by 2045. This escalating prevalence of chronic diseases is expected to drive sustained growth in the demand for heparin-based therapies over the forecast period.

Market Challenges: Raw Material Shortages and Safety Concerns

The heparinoid market faces significant challenges stemming from supply chain constraints and associated safety risks. The production of both Unfractionated Heparin (UFH) and Low Molecular Weight Heparin (LMWH) primarily relies on porcine intestinal mucosa, with China serving as the dominant global supplier.

However, recurrent outbreaks of African Swine Fever (ASF) in China and other regions have resulted in extensive culling of pigs, disrupting the supply of critical raw materials for heparin manufacturing. The European Animal Disease Information System (ADIS) reported 81 ASF outbreaks among domestic pigs across Europe in 2022, highlighting the ongoing risk to global supply chains.

These disruptions pose significant production challenges, potentially affecting market stability and emphasizing the need for strategic sourcing and alternative production approaches.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2293

North America Is Expected to Grow with the Highest CAGR During The Forecast Period

North America holds a dominant position in the global heparinoid market, driven by heightened patient awareness, a substantial disease burden, proactive government initiatives, technological advancements, and robust healthcare infrastructure. The concentration of leading industry players in the region further supports market growth.

According to the Centers for Disease Control and Prevention (CDC, May 2023), heart disease remains the leading cause of mortality in the United States, claiming one life every 33 seconds. This high prevalence of cardiovascular disease underscores the critical role of heparin as a key anticoagulant in the prevention and management of cardiovascular conditions, thereby sustaining consistent demand and reinforcing the region’s market leadership.

Segmentation of Heparinoid Market-

By Raw Material-

• Chondroitin Sulphates
• Dermatan Sulphate
• Heparitin Sulphate

By Application-

• Pharmaceutical
• Dietary Supplements
• Sports Nutrition
• Animal Feed
• Others

By Dosage Form

• Powder
• Capsule

By Region-

North America-

• The US
• Canada
• Mexico

Europe-

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-

• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific

Latin America-

• Brazil
• Argentina
• Rest of Latin America

 Middle East & Africa-

• GCC Countries
• South Africa
• Rest of Middle East and Africa

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Tags: Heparinoid Market